Hudson Bay Capital Management’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.8M Buy
1,952,245
+1,372,672
+237% +$12.5M 0.06% 158
2025
Q1
$4.61M Buy
579,573
+332,573
+135% +$2.64M 0.01% 362
2024
Q4
$1.34M Sell
247,000
-98,000
-28% -$532K ﹤0.01% 539
2024
Q3
$2.49M Buy
345,000
+54,300
+19% +$392K 0.01% 406
2024
Q2
$3.16M Sell
290,700
-84,300
-22% -$915K 0.01% 377
2024
Q1
$7.03M Sell
375,000
-20,000
-5% -$375K 0.04% 192
2023
Q4
$8.56M Buy
395,000
+120,000
+44% +$2.6M 0.05% 173
2023
Q3
$5.66M Buy
275,000
+260,000
+1,733% +$5.35M 0.04% 217
2023
Q2
$705K Sell
15,000
-65,000
-81% -$3.06M 0.01% 545
2023
Q1
$3.36M Sell
80,000
-210,000
-72% -$8.81M 0.03% 369
2022
Q4
$11.1M Sell
290,000
-5,000
-2% -$191K 0.11% 137
2022
Q3
$11.6M Hold
295,000
0.1% 119
2022
Q2
$9.53M Buy
295,000
+250,000
+556% +$8.08M 0.07% 177
2022
Q1
$1.49M Sell
45,000
-5,000
-10% -$166K 0.02% 744
2021
Q4
$2.13M Buy
50,000
+25,000
+100% +$1.06M 0.02% 642
2021
Q3
$1.11M Buy
+25,000
New +$1.11M 0.02% 702
2020
Q3
Sell
-150,000
Closed -$6.24M 602
2020
Q2
$6.24M Buy
150,000
+60,000
+67% +$2.49M 0.11% 162
2020
Q1
$2.59M Buy
+90,000
New +$2.59M 0.06% 228
2019
Q4
Sell
-10,000
Closed -$1.4M 475
2019
Q3
$1.4M Hold
10,000
0.04% 268
2019
Q2
$1.83M Sell
10,000
-10,000
-50% -$1.83M 0.04% 257
2019
Q1
$3.18M Hold
20,000
0.04% 216
2018
Q4
$1.92M Buy
+20,000
New +$1.92M 0.03% 280
2017
Q4
Sell
-10,000
Closed -$623K 420
2017
Q3
$623K Buy
+10,000
New +$623K 0.02% 258
2017
Q2
Hold
0
502